Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up.
about
Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Eculizumab for the treatment o ...... eport with a 5-year follow-up.
@en
Eculizumab for the treatment o ...... eport with a 5-year follow-up.
@nl
type
label
Eculizumab for the treatment o ...... eport with a 5-year follow-up.
@en
Eculizumab for the treatment o ...... eport with a 5-year follow-up.
@nl
prefLabel
Eculizumab for the treatment o ...... eport with a 5-year follow-up.
@en
Eculizumab for the treatment o ...... eport with a 5-year follow-up.
@nl
P2093
P2860
P1476
Eculizumab for the treatment o ...... eport with a 5-year follow-up.
@en
P2093
Hideki Ishida
Kazunari Tanabe
Kazuya Omoto
Kohei Unagami
Masayoshi Okumi
P2860
P304
P356
10.1007/S11255-016-1234-Y
P577
2016-02-10T00:00:00Z